Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Extended release aflibercept with sustained vitreous concentration in non-human primates from biodegradable hydrogel implants

Gary Owens; Melissa Sandahl; Janet Tully; Jennifer Haley; Kwadwo Caesar; Stuart Williams; Rozemarijn S Verhoeven; Andres Garcia; Tomas Navratil; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):409. doi:

ARVO Annual Meeting Abstract September 2016

In vitro and In vivo Sustained Release of Dexamethasone from a PRINT Microparticle Suspension

Melissa Sandahl; Melissa Hernandez; Janet Tully; Gary owens; Rozemarijn S Verhoeven; RiLee Robeson; Stuart Williams; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4023. doi:

ARVO Annual Meeting Abstract September 2016

Extended Release of anti-VEGF Biologics from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration

Gary Owens; Melissa Sandahl; Melissa Hernandez; Andres Garcia; Stuart Williams; Tomas Navratil; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):527. doi:

ARVO Annual Meeting Abstract June 2015

In-Vitro Release of Bevacizumab from Hydrogel-based Drug Delivery Systems

Janet Tully; Stuart Williams; Kevin Herlihy; Gary Owens; Gabe Fawcett; Nicole Meyer; Tomas Navratil; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):222. doi:

ARVO Annual Meeting Abstract June 2015

EXTENDED RELEASE BEVACIZUMAB INTRAVITREAL IMPLANT IS WELL TOLERATED IN THE AFRICAN GREEN MONKEY

Rozemarijn S Verhoeven; Stuart Williams; Jinny Conley; Gary Owens; Matthew S Lawrence; Tomas Navratil; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):230. doi:

ARVO Annual Meeting Abstract June 2015

ESTABLISHING IN VIVO TO IN VITRO CORRELATIONS FOR THE RATE OF RELEASE OF BEVACIZUMAB FROM EXTENDED RELEASE FORMULATIONS

Gary Owens; Stuart Williams; Kevin Herlihy; Janet Tully; Rozemarijn S Verhoeven; Tomas Navratil; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):236. doi:

ARVO Annual Meeting Abstract April 2014

Photocurable Hydrogel Implants for the Extended Release of Bevacizumab for the Treatment of Age Related Macular Degeneration

Stuart Williams; Kevin Herlihy; Gary Owens; John Savage; Lindsay Gardner; Janet Tully; Benjamin Maynor; Tomas Navratil; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):471. doi:

ARVO Annual Meeting Abstract April 2014

Bioerodable Hydrophobic Intravitreal Implants for the Extended Release of Bevacizumab for Age Related Macular Degeneration

John Savage; Kevin Patrick Herlihy; Gary Owens; Jeremy Hansen; RiLee Robeson; Benjamin Maynor; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1951. doi:

ARVO Annual Meeting Abstract April 2014

Extended Release of Microfabricated Protein Particles from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration

Kevin Patrick Herlihy; Stuart Williams; Gary Owens; John Savage; Lindsay Gardner; RiLee Robeson; Benjamin Maynor; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1960. doi:

ARVO Annual Meeting Abstract April 2014

Development of Precisely-Engineered Biodegradable Drug Delivery Systems for Posterior Ocular Drug Delivery: PRINT® PLGA Extended Release Implants for anti-VEGF Biologics

Benjamin Maynor; Andres Garcia; Janet Tully; Gary Owens; RiLee Robeson; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5269. doi:

Advertisement